Drug-induced hepatitis can be caused by an abnormal immunological resp
onse. In the case of tienilic acid- and dihydralazine-induced hepatiti
s, we postulated a scheme in which a P450 produced a reactive metaboli
te (step 1); this reactive metabolite bound to the P450 producing it (
step 2) leading to a neoantigen triggering the immune response (step 3
); the autoantibodies produced during the immune response recognized t
he P450 producing the reactive metabolite (step 4). The use of microor
ganisims (yeast or bacteria) expressing cloned human P450 helped in pr
oving some steps of this postulated scheme, particularly steps 1 and 4
.